Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083809 · ClinicalTrials.gov registry record · NA
Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
A NA study, sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT02083809: Completed NA study, sponsored by University of Hawaii.
NCT02083809 is a NA study that has completed, run by University of Hawaii. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02083809, a NA study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
Currently, there is very little research to identify ways to decrease blood loss during D\&E (dilation and evacuation) procedures. The objective is to determine whether routine use of intravenous oxytocin will improve bleeding outcomes at the time of D\&E at 18-24-weeks gestation. To evaluate the hypothesis, investigators will perform a randomized, double-blinded, placebo-controlled trial. The patient will be followed until discharged from the postoperative care unit during which time patient satisfaction, pain score and postoperative bleeding will be assessed.
Interventions
- DRUG intravenous oxytocin
- DRUG Intravenous Fluids and Electrolytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-02 |
| Phase | NA |
What the finished NCT02083809 record still lists
NCT02083809 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which intravenous oxytocin is the first listed.
NCT02083809 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02083809 about?
NCT02083809 is a clinical study titled "Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation". Currently, there is very little research to identify ways to decrease blood loss during D\&E (dilation and evacuation) procedures. The objective is to determine whether routine use of intravenous oxytocin will improve bleeding outcomes at the time of D\&E at 18-24-weeks gestation. To evaluate the hy...
What is the current status of trial NCT02083809?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2014-10. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02083809?
The interventions under investigation include: intravenous oxytocin (DRUG), Intravenous Fluids and Electrolytes (DRUG).
Who is sponsoring clinical trial NCT02083809?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02083809's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia